Comparison of Nevirapine Levels With and Without Dose Escalation in HIV-Infected Patients Commencing Antiretroviral Therapy Who Are Also Receiving Rifampicin Based Anti-Tuberculous Therapy

Trial Profile

Comparison of Nevirapine Levels With and Without Dose Escalation in HIV-Infected Patients Commencing Antiretroviral Therapy Who Are Also Receiving Rifampicin Based Anti-Tuberculous Therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Dec 2010

At a glance

  • Drugs Nevirapine (Primary) ; Lamivudine; Lamivudine/stavudine/nevirapine; Rifampicin; Stavudine
  • Indications HIV infections; Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 03 Dec 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Apr 2008 Planned start date changed from Feb 2008 to May 2008 according to clinicaltrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top